文献速递精神分裂症与精神病性障碍心境障碍

多基因风险评分与精神分裂症及分裂型症状维度的关系

Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.
PubMed 文献 · Br J Psychiatry · 2023-01-01

该研究在861名爱尔兰高密度多重精神分裂症家系成员中,利用精神分裂症、双相障碍和重性抑郁障碍的全基因组数据构建多基因风险评分(PRS),评估其与精神病性症状维度的关联。结果显示精神分裂症PRS与有精神病发作史者的阴性/紊乱症状维度及无发作史者的阴性维度显著相关,双相障碍PRS与有发作史者的躁狂症状维度显著相关,而重性抑郁障碍PRS无显著关联。结论支持精神分裂症的谱系模型,提示阴性及紊乱症状可能具有更强的遗传基础。

要点

  • 精神分裂症PRS与有精神病发作史者的阴性/紊乱症状维度显著相关(P=2.31×10-4)。
  • 精神分裂症PRS与无精神病发作史者的阴性症状维度显著相关(P=1.42×10-3)。
  • 双相障碍PRS与有精神病发作史者的躁狂症状维度显著相关(P=3.70×10-4)。

核心结论

  • 精神分裂症多基因易感性与多重家系中有精神病发作史者的阴性/紊乱症状及无发作史者的阴性症状相关,支持精神分裂症谱系模型。

研究设计与样本

  • 研究纳入861名来自爱尔兰高密度多重精神分裂症家系的参与者,使用精神分裂症、双相障碍和重性抑郁障碍的最大全基因组数据集构建PRS。
  • 症状维度分别采用精神病性障碍操作标准清单(有精神病发作史者)和分裂型人格结构化访谈(无精神病发作史者)评估,并使用混合效应线性回归模型分析。

主要发现

  • 精神分裂症PRS与有精神病发作史者的阴性/紊乱症状维度显著关联(P=2.31×10-4)。
  • 精神分裂症PRS与无精神病发作史者的阴性症状维度显著关联(P=1.42×10-3)。
  • 双相障碍PRS与有精神病发作史者的躁狂症状维度显著关联(P=3.70×10-4)。
  • 未观察到重性抑郁障碍PRS与任何症状维度的关联。

关键数值与推荐

  • 精神分裂症PRS与阴性/紊乱症状维度关联的显著性阈值为P=2.31×10-4(有精神病发作史者)。
  • 精神分裂症PRS与阴性症状维度关联的显著性阈值为P=1.42×10-3(无精神病发作史者)。
  • 双相障碍PRS与躁狂症状维度关联的显著性阈值为P=3.70×10-4(有精神病发作史者)。

临床怎么用

  • 在多重精神分裂症家系中,精神分裂症PRS可能有助于识别以阴性或紊乱症状为主要表现的高遗传风险个体。
  • 双相障碍PRS与躁狂症状的关联提示在评估精神病风险时需关注双相谱系症状的遗传负荷。

局限性

  • 研究仅基于爱尔兰高密度多重精神分裂症家系,结果外推至一般人群或其他族群需谨慎。
  • 重性抑郁障碍PRS未显示关联,可能受样本量或PRS构建方法限制,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychotic disorders and schizotypal traits aggregate in the relatives of probands with schizophrenia. It is currently unclear how variability in symptom dimensions in schizophrenia probands and their relatives is associated with polygenic liability to psychiatric disorders. AIMS: To investigate whether polygenic risk scores (PRSs) can predict symptom dimensions in members of multiplex families with schizophrenia. METHOD: The largest genome-wide data-sets for schizophrenia, bipolar disorder and major depressive disorder were used to construct PRSs in 861 participants from the Irish Study of High-Density Multiplex Schizophrenia Families. Symptom dimensions were derived using the Operational Criteria Checklist for Psychotic Disorders in participants with a history of a psychotic episode, and the Structured Interview for Schizotypy in participants without a history of a psychotic episode. Mixed-effects linear regression models were used to assess the relationship between PRS and symptom dimensions across the psychosis spectrum. RESULTS: Schizophrenia PRS is significantly associated with the negative/disorganised symptom dimension in participants with a history of a psychotic episode (P = 2.31 × 10-4) and negative dimension in participants without a history of a psychotic episode (P = 1.42 × 10-3). Bipolar disorder PRS is significantly associated with the manic symptom dimension in participants with a history of a psychotic episode (P = 3.70 × 10-4). No association with major depressive disorder PRS was observed. CONCLUSIONS: Polygenic liability to schizophrenia is associated with higher negative/disorganised symptoms in participants with a history of a psychotic episode and negative symptoms in participants without a history of a psychotic episode in multiplex families with schizophrenia. These results provide genetic evidence in support of the spectrum model of schizophrenia, and support the view that negative and disorganised symptoms may have greater genetic basis than positive symptoms, making them better indices of familial liability to schizophrenia.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ahangari M, Bustamante D, Kirkpatrick R, et al. Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia. Br J Psychiatry. 2023. PMID: 36503694. doi:10.1192/bjp.2022.179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。